{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:25:34Z","timestamp":1770823534542,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T00:00:00Z","timestamp":1132704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00277-005-0031-y","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T00:41:11Z","timestamp":1132706471000},"page":"95-101","source":"Crossref","is-referenced-by-count":14,"title":["Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis"],"prefix":"10.1007","volume":"85","author":[{"given":"He","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Lingyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yi-Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Shao-Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,23]]},"reference":[{"key":"31_CR1","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/sj.onc.1203854","volume":"19","author":"R Baserga","year":"2000","unstructured":"Baserga R (2000) The contradictions of the insulin-like growth factor 1 receptor. Oncogene 19:5574\u20135581","journal-title":"Oncogene"},{"key":"31_CR2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K","volume":"168","author":"Y Wu","year":"1996","unstructured":"Wu Y, Tewari M, Cui S et al (1996) Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J Cell Physiol 168:499\u2013509","journal-title":"J Cell Physiol"},{"key":"31_CR3","first-page":"3264","volume":"59","author":"D Coppola","year":"1999","unstructured":"Coppola D, Saunders B, Fu L et al (1999) The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression. Cancer Res 59:3264\u20133270","journal-title":"Cancer Res"},{"key":"31_CR4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0002-9440(10)64220-4","volume":"161","author":"V Poulaki","year":"2002","unstructured":"Poulaki V, Mitsiades CS, Kotoula V et al (2002) Regulation of Apo2L\/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am J Pathol 161:643\u2013654","journal-title":"Am J Pathol"},{"key":"31_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4615-3940-7_5","volume":"53","author":"D Yee","year":"1991","unstructured":"Yee D, Rosen N, Favone RE et al (1991) The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat Res 53:93\u2013106","journal-title":"Cancer Treat Res"},{"key":"31_CR6","first-page":"4522","volume":"56","author":"JR Singleton","year":"1996","unstructured":"Singleton JR, Randolph AE, Feldman EL (1996) Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 56:4522\u20134529","journal-title":"Cancer Res"},{"key":"31_CR7","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1038\/sj.onc.1206772","volume":"22","author":"E Surmacz","year":"2003","unstructured":"Surmacz E (2003) Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 22:6589\u20136597","journal-title":"Oncogene"},{"issue":"2","key":"31_CR8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ijc.20543","volume":"113","author":"L Goetsch","year":"2005","unstructured":"Goetsch L, Gonzalez A, Leger O, Beck A, Pauwels PJ, Haeuw JF, Corvaia N (2005) A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. Int J Cancer 113(2):316\u2013328","journal-title":"Int J Cancer"},{"issue":"4","key":"31_CR9","doi-asserted-by":"crossref","first-page":"R570","DOI":"10.1186\/bcr1028","volume":"7","author":"A Camirand","year":"2005","unstructured":"Camirand A, Zakikhani M, Young F, Pollak M (2005) Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells. Breast Cancer Res 7(4):R570\u2013R579","journal-title":"Breast Cancer Res"},{"key":"31_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajh.2830480302","volume":"48","author":"A Raza","year":"1995","unstructured":"Raza A, Mundle S, Iftikhar A, et al (1995) Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 48:143\u2013154","journal-title":"Am J Hematol"},{"issue":"6","key":"31_CR11","first-page":"954","volume":"24","author":"TB Morrison","year":"1998","unstructured":"Morrison TB, Weis JJ, Wittwer CT (1998) Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24(6):954\u2013958, 960, 962","journal-title":"Biotechniques"},{"key":"31_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0145-2126(94)00133-U","volume":"19","author":"I Shimon","year":"1995","unstructured":"Shimon I, Shpilberg O (1995) The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res 19:233\u2013240","journal-title":"Leuk Res"},{"key":"31_CR13","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V94.11.3653","volume":"94","author":"W Zumkeller","year":"1999","unstructured":"Zumkeller W, Burdach S (1999) The insulin-like growth factor system in normal and malignant hematopoietic cells. Blood 94:3653\u20133657","journal-title":"Blood"},{"issue":"6\u20137","key":"31_CR14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/0959-8049(92)90466-F","volume":"28A","author":"TG Baier","year":"1992","unstructured":"Baier TG, Ludwig WD, Schonberg D, Hartman KK (1992) Characterisation of insulin-like growth factor I receptors of human acute lymphoblastic leukaemia (ALL) cell lines and primary ALL cells. Eur J Cancer 28A(6\u20137):1105\u20131110","journal-title":"Eur J Cancer"},{"issue":"1","key":"31_CR15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2141.2005.05579.x","volume":"130","author":"R Schillaci","year":"2005","unstructured":"Schillaci R, GaleanoA, Becu-Villalobos D, Spinelli O, Sapia S, Bezares RF (2005) Autocrine\/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia. Br J Haematol 130(1):58\u201366","journal-title":"Br J Haematol"},{"issue":"3","key":"31_CR16","first-page":"483","volume":"13","author":"Q He","year":"2005","unstructured":"He Q, Li X, Tao Y, Liu YZ, Yang LP, Ying SX (2005) Expression of insulin-like growth factor receptor type I in marrow nucleated cells from hematologic malignancies and its anti-apoptotic effect. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13(3):483\u2013487","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"31_CR17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1210\/endo.138.1.4847","volume":"138","author":"YM Li","year":"1997","unstructured":"Li YM, Schacher DH, Liu Q, Arkins S, Rebeiz N, McCusker RH Jr, Dantzer R, Kelley KW (1997) Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology 138(1):362\u2013368","journal-title":"Endocrinology"},{"issue":"16","key":"31_CR18","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1016\/S0021-9258(19)38854-4","volume":"265","author":"M Kellerer","year":"1990","unstructured":"Kellerer M, Obermaier-Kusser B, Ermel B, Wallner U, Haring HU, Petrides PE (1990) An altered IGF-I receptor is present in human leukemic cells. J Biol Chem 265(16):9340\u20139345","journal-title":"J Biol Chem"},{"issue":"11","key":"31_CR19","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1091\/mbc.e03-11-0853","volume":"15","author":"AM Valverde","year":"2004","unstructured":"Valverde AM, Mur C, Brownlee M, Bentio M (2004) Susceptibility to apoptosis in insulin-like factor-I receptor-deficient brown adipocytes. Mol Biol Cell 15(11):5101\u20135117","journal-title":"Mol Biol Cell"},{"issue":"4","key":"31_CR20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.neo.7900171","volume":"3","author":"R Jasty","year":"2001","unstructured":"Jasty R, Van Golen C, Lin HJ, Solomon G, Heidelberger K, Polverini P, Opipari A, Feldman E, Castle VP (2001) Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines. Neoplasia 3(4):304\u2013313","journal-title":"Neoplasia"},{"issue":"1","key":"31_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1179\/016164105X18151","volume":"27","author":"D Yin","year":"2005","unstructured":"Yin D, Tamaki N, Parent AD, Zhang JH (2005) Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity. Neurol Res 27(1):27\u201335","journal-title":"Neurol Res"},{"issue":"23","key":"31_CR22","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1158\/0008-5472.CAN-04-2446","volume":"64","author":"SL Krueckl","year":"2004","unstructured":"Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME (2004) Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Cancer Res 64(23):8620\u20138629","journal-title":"Cancer Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-005-0031-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-005-0031-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T06:35:40Z","timestamp":1626762940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-005-0031-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["31"],"URL":"https:\/\/doi.org\/10.1007\/s00277-005-0031-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,23]]}}}